Aker BioMarine
AKBM | OL
Overview
Corporate Details
- ISIN(s):
- NO0010886625 (+1 more)
- LEI:
- 549300V34T6VWDSYWE64
- Country:
- Norway
- Address:
- Oksenøyveien 10, 1366 Lysaker
- Website:
- https://www.akerbiomarine.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Aker BioMarine was created because of our strong belief in the positive health effects of krill. More than a decade later, our business continues to grow because we take care of the ecosystem we harvest in. To us, it makes no sense to take something out of the ocean to improve our health, if it simultaneously compromises the health of the ocean. Ensuring the well-being of the krill biomass and contributing towards a thriving Antarctic ecosystem are among our core priorities. The unique phospholipid-bound omega-3s in krill can help reduce the risk of several lifestyle diseases, including heart and brain-related issues. Aker BioMarine has taken on a global challenge to raise awareness about the importance of omega-3s. In 2020, 1,6 billion doses of Superba Krill were sold worldwide, improving the health of millions of people.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-20 16:48 |
Delisting Announcement
Euronext Oslo Børs – Aker BioMarine ASA - Mottatt søknad om notering av obligas…
|
Norwegian | 572 bytes | |
| 2025-06-20 16:48 |
Delisting Announcement
Euronext Oslo Børs – Aker BioMarine ASA - Received application for listing of b…
|
Norwegian | 622 bytes | |
| 2025-06-16 14:00 |
Prospectus
Aker BioMarine ASA – Base prospectus approved for listing of bonds - Attachment…
|
English | 2.3 MB | |
| 2025-06-16 14:00 |
Prospectus
Aker BioMarine ASA – Base prospectus approved for listing of bonds
|
English | 1.8 KB | |
| 2025-05-02 12:45 |
Directors' Dealings
Mandatory notification of trade
|
Norwegian | 129.3 KB | |
| 2025-05-02 12:45 |
Directors' Dealings
Mandatory notification of trade
|
English | 1.4 KB | |
| 2025-04-30 05:00 |
Earnings Release
First quarter 2025 results for Aker BioMarine
|
English | 1.4 MB | |
| 2025-04-30 05:00 |
Earnings Release
First quarter 2025 results for Aker BioMarine
|
English | 4.3 KB | |
| 2025-04-28 16:00 |
Earnings Release
Aker BioMarine ASA – Invitation to presentation of the first quarter 2025 resul…
|
English | 1.8 KB | |
| 2025-04-26 07:05 |
Declaration of Voting Results & Voting Rights Announcements
Aker BioMarine ASA – Minutes of Annual General Meeting
|
Norwegian | 223.3 KB | |
| 2025-04-26 07:05 |
Declaration of Voting Results & Voting Rights Announcements
Aker BioMarine ASA – Minutes of Annual General Meeting
|
Norwegian | 751.1 KB | |
| 2025-04-26 07:05 |
Declaration of Voting Results & Voting Rights Announcements
Aker BioMarine ASA – Minutes of Annual General Meeting
|
English | 1.5 KB | |
| 2025-04-02 06:15 |
Proxy Solicitation & Information Statements
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
Norwegian | 206.2 KB | |
| 2025-04-02 06:15 |
General Meeting Notice
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
English | 112.5 KB | |
| 2025-04-02 06:15 |
Remuneration Report
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
English | 2.0 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |